EN
HI
Goldline Pharmaceutical Chart
Goldline Pharmaceutical Share Key Metrics
Volume
1.17 L
Market Cap
42.43 CR
LTQ@LTP
3000@43.65
ATP
43.22
Var Margin
53.5 %
Circuit Range
35.36-53.04
Delivery %
90.48 %
Value
50.57 L
ASM/GSM
No
Market Lot
3000
Summary
Goldline Pharmaceutical share price is ₹43.65 as of 10 Jun, 2026. The stock Goldline Pharmaceutical intraday movement has stayed between ₹42.30 and ₹44.20, while on a 52-week basis,Goldline Pharmaceutical price 52 week high is ₹60.00 & its 52 week low is ₹41.76.
In terms of trading activity, Goldline Pharmaceutical has recorded a volume of 117000 shares, The Goldline Pharmaceutical has a market cap of ₹9600000 CR. The stock’s Average Traded Price (ATP) stands at ₹43.22, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3000 @ ₹43.65.
Goldline Pharmaceutical operates within a circuit range of ₹35.36 – ₹53.04, with a Value of ₹50.57 L. The Delivery Percentage for the day is 90.48%. Additionally, Goldline Pharmaceutical currently falls under the No framework, and trades with a market lot size of 3000.
Goldline Pharmaceutical Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
67.41
Sector P/B
2.96
Sec. Div. Yield
0.54
Goldline Pharmaceutical Resistance and Support
Pivot 44.15
Resistance
First Resistance
45.04
Second Resistance
45.89
Third Resistance
46.78
Support
First Support
43.3
Second Support
42.41
Third Support
41.56
Goldline Pharmaceutical Corporate Actions
| Date | Agenda |
|---|---|
| 2026-06-09 | Audited Results |
Goldline Pharmaceutical News
Goldline Pharmaceutical Ltd - 544759 - Board Meeting Outcome for Outcome Of Board Meeting Held Today, I.E., 09Th June, 2026
Goldline Pharmaceutical's board approved audited FY26 financial results, with revenue growing 11.20% YoY to ₹31.20 crores and net profit increasing 45.26% YoY to ₹4.12 crores. The board also appointed M/s. Kunal Dutt & Associates as the internal auditor from FY27.
Jun 09 2026 19:00:27
Goldline Pharmaceutical Ltd - 544759 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 To Be Held On Tuesday, June 09, 2026.
Goldline Pharmaceutical will hold a board meeting on June 9, 2026. The meeting agenda includes the consideration and approval of standalone audited financial results for the half-year and full year ended March 31, 2026.
Jun 02 2026 16:01:14
Goldline Pharmaceutical Management
| Name | Position |
|---|---|
| Amol Laxmikant Mujumdar | Chairman & Managing Director |
| Swapan Premprakash Khandelwal | Whole Time Director |
Goldline Pharmaceutical Similar Stocks
Goldline Pharmaceutical FAQs
The Buying Price of Goldline Pharmaceutical share is 43.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Goldline Pharmaceutical stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Goldline Pharmaceutical, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Goldline Pharmaceutical shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Goldline Pharmaceutical shares is 0. Useful to assess the stock's value relative to its book value.
To assess Goldline Pharmaceutical’s valuation compare Sector P/E, P/B which are 67.41 & 2.96 with sector averages, along with growth rates and financial metrics.
The Market Cap of Goldline Pharmaceutical is 42.43 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Goldline Pharmaceutical share price is 60.00 & 41.76. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Goldline Pharmaceutical belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
